Clinical Trials Logo

Hip Fracture Surgery clinical trials

View clinical trials related to Hip Fracture Surgery.

Filter by:
  • None
  • Page 1

NCT ID: NCT05857462 Recruiting - Hip Fractures Clinical Trials

The Impact of Integrated Preoperative Fascia Iliaca Compartment Block in Elderly Hip Fracture

Start date: May 2023
Phase: N/A
Study type: Interventional

This prospective randomized controlled study is aimed to determine the advantages of post-admission fascia iliaca compartment block (FICB) in geriatric hip fracture surgery combination with multimodal analgesia compared with no post-admission FICB. The primary outcome is incidence of delirium during hospital admission. Secondary outcomes are incidence of delirium at hospital discharge, pre- and post-operative pain intensity, peri-operative complications, opioid-related side effects, post-operative complications and length of hospital stay, and morbidities and mortality (in-hospital and 30 days).

NCT ID: NCT05810012 Completed - Clinical trials for Hip Fracture Surgery

Comparison of Analgesic Efficacy of PENB Block With FICB in Post Operative Hip Fracture Patients

Start date: April 1, 2022
Phase: Phase 2
Study type: Interventional

This study was done to evaluate two different interventions for postoperative pain control in patients undergoing hip surgeries. Fifty patients, divided in two equal groups, were included in the study. Patients in Group P were given pericapsular nerve group (PENG) block while those in Group F were given fascia iliaca compartment block (FICB). Pain score, using Numeric Rating scale as a measurement tool, was assessed at one, six, eighteen and twenty fours after the procedure as a primary outcome. Total tramadol consumption in milligrams was recorded as a secondary outcome.

NCT ID: NCT05096507 Recruiting - Clinical trials for Postoperative Delirium

Cytokines, POD, Health Status, Older Hip Fracture

Start date: June 6, 2022
Phase:
Study type: Observational

An investigation of the change in inflammation marker levels across hip fracture surgery and an exploration of any association with change in self reported health status and incidence of postoperative delirium

NCT ID: NCT04955249 Recruiting - Elderly Clinical Trials

Dexmedetomidine Supplemented Analgesia and Delirium After Hip Fracture Surgery

Start date: November 18, 2021
Phase: Phase 4
Study type: Interventional

Delirium is common in the elderly after hip fracture surgery, and is associated with worse outcomes. The investigators hypothesize that, for elderly patients after hip fracture surgery, dexmedetomidine supplemented analgesia can reduce the incidence of delirium and improve the long-term outcomes.

NCT ID: NCT03429010 Recruiting - Anesthesia Clinical Trials

Efficacy of Perioperative Anesthesia Care Bundle on Prognosis in Elderly Undergoing Hip Fracture Surgery

EPAPHUS
Start date: July 1, 2018
Phase: N/A
Study type: Interventional

This study is going to research the hypothesis that to strengthen the comprehensive treatment of perioperative anesthesia is possible to improve the prognosis of patients with hip fracture and reduce mortality. This is a randomized controlled pilot study aimed to elderly patients with hip fracture on one side and needing surgical treatment.

NCT ID: NCT02556658 Completed - Clinical trials for Hip Fracture Surgery

Predicted Level of General Anaesthesia in Hip Fracture Surgery

NAPfem
Start date: February 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate if prediction of general anaesthesia level by the Smartpilot® View device can improve the quality of anaesthesia in patients undergoing hip fracture surgery.

NCT ID: NCT01352039 Terminated - Clinical trials for Hip Fracture Surgery

A Non-inferiority Study Comparing Two Heparin Sodium Preparations in Hip Fracture Surgery

HEP-SC
Start date: October 2011
Phase: Phase 3
Study type: Interventional

The primary objective and endpoints of the study is compare the efficacy of two products containing heparin sodium, evaluating if the formulation produced by Eurofarma can be considered non-inferior to the reference product.